Ann C. Mladek

Also affiliated with Mayo Clinic Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Quantitative analysis of tyrosine phosphorylation from FFPE tissues reveals patient specific signaling networks”.

Quantitative analysis of tyrosine phosphorylation from FFPE tissues reveals patient specific signaling networks

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.10.291922

N/A

0DataRank · unranked

2 citations

Danielle M. Burgenske, Ann C. Mladek, Katrina K. Bakken, Jenevieve Kuang, Judy C. Boughey +7 more

Multimodal platform for assessing drug distribution and response in clinical trials

Neuro-Oncology(2021)10.1093/neuonc/noab197

N/A

0DataRank · unranked

14 citations

Ishwar N. Kohale, Ziming Du, Ilya Korsunsky, Walid M. Abdelmoula, Yang Dai +23 more

Factors Influencing Luciferase-Based Bioluminescent Imaging in Preclinical Models of Brain Tumor

Drug Metabolism and Disposition(2021)10.1124/dmd.121.000597

N/A

0DataRank · unranked

12 citations

Shiv K. Gupta, Wenjuan Zhang, Surabhi Talele, Afroz S. Mohammad, Janice K. Laramy +5 more

Protein kinase Cι and SRC signaling define reciprocally related subgroups of glioblastoma with distinct therapeutic vulnerabilities

Cell Reports(2021)10.1016/j.celrep.2021.110054

N/A

0DataRank · unranked

10 citations

Yi Liu, Michael Argenziano, Matei A. Banu, Ann C. Mladek, Rita West +12 more

RBBP4-p300 axis modulates expression of genes essential for cell survival and is a potential target for therapy in glioblastoma

Neuro-Oncology(2022)10.1093/neuonc/noac051

N/A

0DataRank · unranked

27 citations

Huihuang Yan, Shulan Tian, Paul A. Decker, Danielle M. Burgenske, Katrina K. Bakken +11 more

Convection enhanced delivery of EGFR targeting antibody-drug conjugates Serclutamab talirine and Depatux-M in glioblastoma patient-derived xenografts

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac130

N/A

0DataRank · unranked

13 citations

Michael S. Regan, Jessica I. Griffith, Sonia Jain, Sylwia A. Stopka, Danielle M. Burgenske +19 more

Central Nervous System Delivery of the Catalytic Subunit of DNA-Dependent Protein Kinase Inhibitor Peposertib as Radiosensitizer for Brain Metastases

Journal of Pharmacology and Experimental Therapeutics(2022)10.1124/jpet.121.001069

N/A

0DataRank · unranked

16 citations

Wenjuan Zhang, Ju‐Hee Oh, Danielle M. Burgenske, Ann C. Mladek, Sonja Dragojevic +3 more

Delivery versus Potency in Treating Brain Tumors: BI-907828, a MDM2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in Glioblastoma

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0217

N/A

0DataRank · unranked

8 citations

Rachael A. Vaubel, Ju-Hee Oh, Ann C. Mladek, Surabhi Talele, Wenqiu Zhang +5 more

WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad066

N/A

0DataRank · unranked

5 citations

Sylwia A. Stopka, Ju‐Hee Oh, Ann C. Mladek, Danielle M. Burgenske, Michael S. Regan +15 more

Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis Xenografts

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0552

N/A

0DataRank · unranked

12 citations

Sonja Dragojevic, Cameron M. Callaghan, Emily J. Smith, Surabhi Talele, Wenjuan Zhang +15 more

The novel brain penetrant ataxia-telangiectasia mutated inhibitor WSD0628 provides robust radiosensitization of brain tumor patient-derived xenografts

Neuro-Oncology(2025)10.1093/neuonc/noaf102

N/A

0DataRank · unranked

7 citations

Ann C. Mladek, Sneha Rathi, Sonia Jain, Rachael A. Vaubel, Lateef A Odukoya +17 more

Pre-clinical modeling of navtemadlin pharmacokinetics (PK), pharmacodynamics (PD), and efficacy in glioblastoma, IDH-wildtype.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.2012

N/A

0DataRank · unranked

0 citations

Wenjuan Zhang, Ann C. Mladek, Tugce I. Pasa, Katie L. Waller, Sylwia A. Stopka +15 more

Factors Influencing the Central Nervous System (CNS) Distribution of the Ataxia Telangiectasia Mutated and Rad3-Related Inhibitor Elimusertib (BAY1895344): Implications for the Treatment of CNS Tumors

Journal of Pharmacology and Experimental Therapeutics(2024)10.1124/jpet.123.002002

N/A

0DataRank · unranked

0 citations

Ann C. Mladek, Ju‐Hee Oh, Sonja Dragojevic, Danielle M. Burgenske, Wenjuan Zhang +10 more

Preclinical Modeling of Navtemadlin Pharmacokinetics, Pharmacodynamics, and Efficacy in IDH–Wild-type Glioblastoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-0244

N/A

0DataRank · unranked

2 citations

Wenjuan Zhang, Ju-Hee Oh, Ann C. Mladek, Tugce I. Pasa, Jennifer Gantchev +24 more

Pharmacokinetic-pharmacodynamic-efficacy modeling of the MDM2 inhibitor brigimadlin in glioblastoma patient-derived xenografts

Neuro-Oncology Advances(2025)10.1093/noajnl/vdaf259

N/A

0DataRank · unranked

0 citations

Wenjuan Zhang, Nishika Karbhari, Ju-Hee Oh, Katie L. Waller, Ann C. Mladek +16 more